New Review Articles

    "after a month of taking 2 teaspoons of NeuroShield each morning I was sleeping better, had less irritability, and a clearer mind." JW (Veteran)

 Summary of the Study :  The 2020 Marine Pilot Study, conducted by the Millennium Health Centers, explored the effects of Brain Rescue 3 (BR3)—a nutraceutical blend targeting neuroinflammation—on active-duty Marines suffering from subconcussive and concussive brain injuries. This open-label, 90-day study aimed to assess the intervention's impact on psychological, physiological, and physical functioning. Key ingredients in BR3 included neurosteroids, antioxidants (e.g., N-acetylcysteine, CoQ10), and anti-inflammatory compounds (e.g., DHA, quercetin). Participants self-reported improvements using subjective measures, indicating enhanced cognitive function, reduced migraines, better sleep, and emotional stability. These findings suggest that nutraceuticals addressing inflammation and oxidative stress can complement TBI recovery efforts.

Gerald McClellan in 1995 was a two time world champion middleweight boxer.  Then he wasn't having suffered a defeat by Nigel Benn in London.  What compounded the defeat was a devastating stroke that left him legally blind, emotionally and cognitively compromised and speech impaired. His loving sister Lisa, took Gerald in and for the past 29 years has single handedly address his physical and mental needs. In 2023, Dr. Mark Gordon of the Millennium Health Centers, applied his biomarker panel and treatment technology on Gerald who has started to regain his functioning as discussed by Oliver Fennell in this Boxing Journal article. We are just at the beginning but making strides even after 29 years.  See his short Video:  

Since 2019, we have undertaken the task of accumulating patient outcome data from the Monthly Program Questionnaire (MPQ). The MPQ consists of 25 questions designed for subjective assessment, enabling patients to evaluate their own psychological, physiological, and physical well-being on a scale from 1 to 10, at 30-day intervals while following their treatment protocol. Upon the culmination of a 12-month period, these assessments are meticulously collated and subjected to a straightforward averaging process. The resultant data is primarily intended for internal use within our organization to identify treatment enhancers and detractors. Remarkably, we have amassed 5 years of comprehensive data, constituting a valuable resource for in-depth analysis by other experts in the field as well as by those in need of help. If you are aware of any individuals or professionals with a keen interest in examining the results from these series, we kindly invite you to refer them to Dr. Mark L. Gordon for further exploration and potential collaboration.

Here are a number of peer-reviewed articles in medicine that helped to shape our program.

After reading the current literature on the Covid-19 virus and the science that has been under development since the SARS outbreak of 2003, here are a few articles that tell us what may be our best strategy for defense. Although there are no double-blind studies at this moment, the anecdotal accounts are worth a consideration when you pair them with the known empirical science.  Our patient population, at the Millennium, have been on much of what is presented here and we are doing a survey of their history of infections having seen many patients comment that they just don't get sick like they did before even if exposed at work or home. Coincidental or ? Make sure you read all the references and see the video under MEDIA.